MARKET

VBIV

VBIV

VBI Vaccines
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.580
-0.180
-4.79%
After Hours: 3.640 +0.06 +1.68% 19:51 09/18 EDT
OPEN
3.790
PREV CLOSE
3.760
HIGH
3.794
LOW
3.480
VOLUME
25.45M
TURNOVER
--
52 WEEK HIGH
6.93
52 WEEK LOW
0.4655
MARKET CAP
827.69M
P/E (TTM)
-11.7608
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile

Analyst Price Target

The average VBIV stock price target is 6.75 with a high estimate of 9.00 and a low estimate of 3.000.

Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About VBIV
VBI Vaccines Inc. is a development-stage biotechnology company. The Company's principal products include cytomegalovirus (CMV) Vaccine Candidate, enveloped Virus Like Particle (eVLP) Vaccine Platform and Lipid Particle Vaccine (LPV) Vaccine Platform. The Company is also engaged in the research and development (R and D) activity. The Company's subsidiaries includes Variation Biotechnologies (US), Inc. (VBI US) and Variation Biotechnologies Inc. (VBI Cda).
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of VBI Vaccines Inc stock information, including NASDAQ:VBIV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VBIV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading VBIV stock methods without spending real money on the virtual paper trading platform.